Nucleus accumbens and effort-related functions: behavioral and neural markers of the interactions between adenosine A2A and dopamine D2 receptors

Neuroscience

Volumn 166, Issue 4, 2010, Pages 1056-1067

  Farrar, A M ^a   Segovia, K N ^a   Randall, P A ^a   Nunes, E J ^a   Collins, L E ^a   Stopper, C M ^a   Port, R G ^a   Hockemeyer, J ^b   Muller C E ^b   Correa, M ^a   Salamone, J D ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

anergia; decision making; depression; fatigue; motivation; reward

Indexed keywords

ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR ANTAGONIST; DOPAMINE; DOPAMINE 2 RECEPTOR; ETICLOPRIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN FUNCTION; CARBOHYDRATE INTAKE; CONTROLLED STUDY; DECISION MAKING; DOPAMINE METABOLISM; FATIGUE; FOOD PREFERENCE; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PSYCHOMOTOR DISORDER; RAT; REGULATORY MECHANISM;

ADENOSINE; ANIMALS; BEHAVIOR, ANIMAL; CONDITIONING, OPERANT; DECISION MAKING; DOPAMINE; DOPAMINE ANTAGONISTS; FEEDING BEHAVIOR; MALE; NUCLEUS ACCUMBENS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A2A; RECEPTORS, DOPAMINE D2; SALICYLAMIDES; XANTHINES;

EID: 77349098999     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.12.056     Document Type: Article

References (105)

1. Aberman J.E., and Salamone J.D. Nucleus accumbens dopamine depletions make rats more sensitive to high ratio requirements but do not impair primary food reinforcement. Neuroscience 92 (1999) 545-552
2. Baldo B.A., and Kelley A.E. Discrete neurochemical coding of distinguishable motivational processes: insights from nucleus accumbens control of feeding. Psychopharmacology 191 (2007) 439-459
3. Baldo B.A., Sadeghian K., Basso A.M., and Kelley A.E. Effects of selective dopamine D1 or D2 receptor blockade within nucleus accumbens subregions on ingestive behavior and associated motor activity. Behav Brain Res 137 (2002) 165-177
4. Barbano M.F., and Cador M. Differential regulation of the consummatory, motivational and anticipatory aspects of feeding behavior by dopaminergic and opioidergic drugs. Neuropsychopharmacology 31 (2006) 1371-1381
5. Barbano M.F., and Cador M. Opioids for hedonic experience and dopamine to get ready for it. Psychopharmacology (Berl) 191 (2007) 497-506
6. Bardgett M.E., Depenbrock M., Downs N., Points M., and Green L. Dopamine modulates effort-based decision making in rats. Behav Neurosci 123 (2009) 463-467
7. Barraco R.A., Martens K.A., Parizon M., and Normile H.J. Adenosine A2a receptors in the nucleus accumbens mediate locomotor depression. Brain Res Bull 31 (1993) 397-404
8. Barraco R.A., Martens K.A., Parizon M., and Normile H.J. Role of adenosine A2a receptors in the nucleus accumbens. Prog Neuropsychopharmacol Biol Psychiatry 18 (1994) 545-553
9. 2A antagonist KW-6002 (istradefylline) on pimozide-induced oral tremor and striatal c-Fos expression: comparisons with the muscarinic antagonist tropicamide. Neuroscience 163 (2009) 97-108
10. Boegman R.J., and Vincent S.R. Involvement of adenosine and glutamate receptors in the induction of c-fos in the striatum by haloperidol. Synapse 22 (1996) 70-77
11. Botvinick M.M., Huffstetler S., and McGuire J.T. Effort discounting in human nucleus accumbens. Cogn Affect Behav Neurosci 9 (2009) 16-27
12. Cagniard B., Balsam P.D., Brunner D., and Zhuang X. Mice with chronically elevated dopamine exhibit enhanced motivation, but not learning, for a food reward. Neuropsychopharmacology 31 (2006) 1362-1370
13. Chen J.F., Moratalla R., Impagnatiello F., Grandy D.K., Cuellar B., Rubinstein M., Beilstein M.A., Hacket E., Fink J.S., Low M.J., Ongini E., and Schwarzschild M.A. The role of the D2 dopamine receptor (D2R) in A2a adenenosine-receptor (A2aR) mediated behavioral and cellular responses as revealed by A2a and D2 receptor knockout mice. Proc Natl Acad Sci U S A 98 (2001) 1970-1975
14. Collier G., and Jennings W. Work as a determinant of instrumental performance. J Comp Physiol Psych 68 (1969) 659-662
15. Correa M., Wisniecki A., Betz A., Dobson D.R., O'Neill M.F., O'Neill M.J., and Salamone J.D. The adenosine A2A antagonist KF17837 reverses the locomotor suppression and tremulous jaw movements induced by haloperidol in rats: possible relevance to Parkinsonism. Behav Brain Res 148 (2004) 47-54
16. Cousins M.S., and Salamone J.D. Nucleus accumbens dopamine depletions in rats affect relative response allocation in a novel cost/benefit procedure. Pharmacol Biochem Behav 49 (1994) 85-91
17. Cousins M.S., Sokolowski J.D., and Salamone J.D. Different effects of nucleus accumbens and ventrolateral striatal dopamine depletions on instrumental response selection in the rat. Pharmacol Biochem Behav 46 (1993) 943-951
18. Cousins M.S., Wei W., and Salamone J.D. Pharmacological characterization of performance on a concurrent lever pressing/feeding choice procedure: effects of dopamine antagonist, cholinomimetic, sedative and stimulant drugs. Psychopharmacology (Berl) 116 (1994) 529-537
19. Cousins M.S., Atherton A., Turner L., and Salamone J.D. Nucleus accumbens dopamine depletions alter relative response allocation in a T-maze cost/benefit task. Behav Brain Res 74 (1996) 189-197
20. Croxson P.L., Walton M.E., O'Reilly J.X., Behrens T.E., and Rushworth M.F. Effort-based cost-benefit valuation and the human brain. J Neurosci 29 (2009) 4531-4541
21. DeMet E.M., and Chicz-DeMet A. Localization of adenosine A2A-receptors in rat brain with [3H]ZM-241385. Naunyn Schmiedebergs Arch Pharmacol 366 (2002) 478-481
22. Desmurget M., and Turner R.S. Testing basal ganglia motor functions through reversible inactivations in the posterior internal globus pallidus. J Neurophysiol 99 (2008) 1057-1076
23. Denk F., Walton M.E., Jennings K.A., Sharp T., Rushworth M.F., and Bannerman D.M. Differential involvement of serotonin and dopamine systems in cost-benefit decisions about delay or effort. Psychopharmacology (Berl) 179 (2005) 587-596
24. Dragunow M., Robertson G.S., Faull R.L., Robertson H.A., and Jansen K. D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons. Neuroscience 37 (1990) 287-294
25. Ernst M., and Paulus M.P. Neurobiology of decision making: a selective review from a neurocognitive and clinical perspective. Biol Psychiatry 58 (2005) 597-604
26. Farrar A.M., Pereira M., Velasco F., Hockemeyer J., Muller C.E., and Salamone J.D. Adenosine A(2A) receptor antagonism reverses the effects of dopamine receptor antagonism on instrumental output and effort-related choice in the rat: implications for studies of psychomotor slowing. Psychopharmacology (Berl) 191 (2007) 579-586
27. Farrar A.M., Font L., Pereira M., Mingote S., Bunce J.G., Chrobak J.J., and Salamone J.D. Forebrain circuitry involved in effort-related choice: injections of the GABAA agonist muscimol into ventral pallidum alter response allocation in food-seeking behavior. Neuroscience 152 (2008) 321-330
28. Ferré S. Adenosine-dopamine interactions in the ventral striatum. Implications for the treatment of schizophrenia. Psychopharmacology 133 (1997) 107-120
29. Ferre S., Ciruela F., Canals M., Marcellino D., Burgueno J., Casado V., Hillion J., Torvinen M., Fanelli F., Benedetti Pd P., Goldberg S.R., Bouvier M., Fuxe K., Agnati L.F., Lluis C., Franco R., and Woods A. Adenosine A2A-dopamine D2 receptor-receptor heteromers. Targets for neuro-psychiatric disorders. Parkinsonism Relat Disord 10 (2004) 265-271
30. Ferre S., Fredholm B.B., Morelli M., Popoli P., and Fuxe K. Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci 20 (1997) 482-487
31. Ferre S., Popoli P., Gimenez-Llort L., Rimondini R., Muller C.E., Stromberg I., Ogren S.O., and Fuxe K. Adenosine/dopamine interaction: implications for the treatment of Parkinson's disease. Parkinsonism Relat Disord 7 (2001) 235-241
32. Ferré S., Quiroz C., Woods A.S., Cunha R., Popoli P., Ciruela F., Lluis C., Franco R., Azdad K., and Schiffmann S.N. An update on adenosine A2A-dopamine D2 receptor interactions: implications for the function of G protein-coupled receptors. Curr Pharm Des 14 (2008) 1468-1474
33. Fibiger H.C. Neuroanatomical targets of neuroleptic drugs as revealed by Fos immunochemistry. J Clin Psychiatry 55 Suppl B (1994) 33-36
34. Fink J.S., Weaver D.R., Rivkees S.A., Peterfreund R.A., Pollack A.E., Adler E.M., and Reppert S.M. Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum. Brain Res Mol Brain Res 14 (1992) 186-195
35. Floresco S.B., and Ghods-Sharifi S. Amygdala-prefrontal cortical circuitry regulates effort-based decision making. Cereb Cortex 17 (2007) 251-260
36. Floresco S.B., Tse M.T., and Ghods-Sharifi S. Dopaminergic and glutamatergic regulation of effort- and delay-based decision making. Neuropsychopharmacology 33 (2008) 1966-1979
37. Font L., Mingote S., Farrar A.M., Pereira M., Worden L., Stopper C., Port R.G., and Salamone J.D. Intra-accumbens injections of the adenosine A2A agonist CGS 21680 affect effort-related choice behavior in rats. Psychopharmacology (Berl) 199 (2008) 515-526
38. Fuxe K., Agnati L.F., Jacobsen K., Hillion J., Canals M., Torvinen M., Tinner-Staines B., Staines W., Rosin D., Terasmaa A., Popoli P., Leo G., Vergoni V., Lluis C., Ciruela F., Franco R., and Ferre S. Receptor heteromerization in adenosine A2A receptor signaling: relevance for striatal function and Parkinson's disease. Neurology 61 (2003) S19-S23
39. Gan J.O., Walton M.E., and Phillips P.E. Dissociable cost and benefit encoding of future rewards by mesolimbic dopamine. Nat Neurosci 13 (2009) 25-27
40. Hauber W., and Munkle M. Motor depressant effects mediated by dopamine D2 and adenosine A2A receptors in the nucleus accumbens and the caudate-putamen. Eur J Pharmacol 323 (1997) 127-131
41. Hauber W., Neuscheler P., Nagel J., and Muller C.E. Catalepsy induced by a blockade of dopamine D1 or D2 receptors was reversed by a concomitant blockade of adenosine A(2A) receptors in the caudate-putamen of rats. Eur J Neurosci 14 (2001) 1287-1293
42. Hauber W., and Sommer S. Prefrontostriatal circuitry regulates effort-related decision making. Cereb Cortex 19 (2009) 2240-2247
43. Hettinger B.D., Lee A., Linden J., and Rosin D.L. Ultrastructural localization of adenosine A2A receptors suggests multiple cellular sites for modulation of GABAergic neurons in rat striatum. J Comp Neurol 431 (2001) 331-346
44. Hillion J., Canals M., Torvinen M., Casado V., Scott R., Terasmaa A., Hansson A., Watson S., Olah M.E., Mallol J., Canela E.I., Zoli M., Agnati L.F., Ibanez C.F., Lluis C., Franco R., Ferre S., and Fuxe K. Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors. J Biol Chem 277 (2002) 18091-18097
45. Hockemeyer J., Burbiel J.C., and Muller C.E. Multigram-scale syntheses, stability, and photoreactions of A2A adenosine receptor antagonists with 8-styrylxanthine structure: potential drugs for Parkinson's disease. J Org Chem 69 (2004) 3308-3318
46. Ishiwari K., Madson L.J., Farrar A.M., Mingote S.M., Valenta J.P., DiGianvittorio M.D., Frank L.E., Correa M., Hockemeyer J., Muller C., and Salamone J.D. Injections of the selective adenosine A2A antagonist MSX-3 into the nucleus accumbens core attenuate the locomotor suppression induced by haloperidol in rats. Behav Brain Res 178 (2007) 190-199
47. Ishiwari K., Weber S.M., Mingote S., Correa M., and Salamone J.D. Accumbens dopamine and the regulation of effort in food-seeking behavior: modulation of work output by different ratio or force requirements. Behav Brain Res 151 (2004) 83-91
48. Jarvis M.F., and Williams M. Direct autoradiographic localization of adenosine A2 receptors in the rat brain using the A2-selective agonist, [3H]CGS 21680. Eur J Pharmacol 168 (1989) 243-246
49. Kelley A.E., Baldo B.A., Pratt W.E., and Will M.J. Corticostriatal-hypothalamic circuitry and food motivation: integration of energy, action and reward. Physiol Behav 86 (2005) 773-795
50. Keppel G. Design and analysis: a researchers handbook (1991), Prentice-Hall, Englewood Cliffs, NJ
51. Koch M., Schmid A., and Schnitzler H.U. Role of nucleus accumbens dopamine D1 and D2 receptors in instrumental and Pavlovian paradigms of conditioned reward. Psychopharmacology 152 (2000) 67-73
52. Koob G.F., Riley S.J., Smith S.C., and Robbins T.W. Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi and olfactory tubercle on feeding, locomotor activity, and amphetamine anorexia in the rat. J Comp Physiol Psychol 92 (1978) 917-927
53. MacGibbon G.A., Lawlor P.A., Bravo R., and Dragunow M. Clozapine and haloperidol produce a differential pattern of immediate early gene expression in rat caudate-putamen, nucleus accumbens, lateral septum and islands of Calleja. Brain Res Mol Brain Res 23 (1994) 21-32
54. McCullough L.D., Sokolowski J.D., and Salamone J.D. A neurochemical and behavioral investigation of the involvement of nucleus accumbens dopamine in instrumental avoidance. Neuroscience 52 (1993) 919-925
55. Miller J.C. Induction of c-fos mRNA expression in rat striatum by neuroleptic drugs. J Neurochem 54 (1990) 1453-1455
56. Mingote S., Font L., Farrar A.M., Vontell R., Worden L.T., Stopper C.M., Port R.G., Sink K.S., Bunce J.G., Chrobak J.J., and Salamone J.D. Nucleus accumbens adenosine A2A receptors regulate exertion of effort by acting on the ventral striatopallidal pathway. J Neurosci 28 (2008) 9037-9046
57. Morelli M., and Pinna A. Interaction between dopamine and adenosine A2A receptors as a basis for the treatment of Parkinson's disease. Neurol Sci 22 (2001) 71-72
58. Mott A.M., Nunes E.J., Collins L.E., Port R.G., Sink K.S., Hockemeyer J., Muller C.E., and Salamone J.D. The adenosine A2A antagonist MSX-3 reverses the effects of the dopamine antagonist haloperidol on effort-related decision making in a T-maze cost/benefit procedure. Psychopharmacology (Berl) 204 (2009) 103-112
59. Niv Y., Daw N.D., Joel D., and Dayan P. Tonic dopamine: opportunity costs and the control of response vigor. Psychopharmacology (Berl) 191 (2007) 507-520
60. Nowend K.L., Arizzi M., Carlson B.B., and Salamone J.D. D1 or D2 antagonism in nucleus accumbens core or dorsomedial shell suppresses lever pressing for food but leads to compensatory increases in chow consumption. Pharmacol Biochem Behav 69 (2001) 373-382
61. Pellegrino L.J., Pellegrino A.S., and Cushman A.J. A stereotaxic atlas of the rat brain (1979), Plenum, New York
62. Phillips P.E., Walton M.E., and Jhou T.C. Calculating utility: preclinical evidence for cost-benefit analysis by mesolimbic dopamine. Psychopharmacology (Berl) 191 (2007) 483-495
63. Pinna A., Wardas J., Cristalli G., and Morelli M. Adenosine A2A receptor agonists increase Fos-like immunoreactivity in mesolimbic areas. Brain Res 759 (1997) 41-49
64. Pinna A., Wardas J., Cozzolino A., and Morelli M. Involvement of adenosine A2A receptors in the induction of c-fos expression by clozapine and haloperidol. Neuropsychopharmacology 20 (1999) 44-51
65. Pinna A., Wardas J., Simola N., and Morelli M. New therapies for the treatment of Parkinson's disease: adenosine A2A receptor antagonists. Life Sci 77 (2005) 3259-3267
66. Robertson G.S., and Fibiger H.C. Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine. Neuroscience 46 (1992) 315-328
67. Rushworth M.F., Walton M.E., Kennerley S.W., and Bannerman D.M. Action sets and decisions in the medial frontal cortex. Trends Cogn Sci 8 (2004) 410-417
68. Salamone J.D. Complex motor and sensorimotor functions of striatal and accumbens dopamine: involvement in instrumental behavior processes. Psychopharmacology 107 (1992) 160-174
69. Salamone J.D. Involvement of nucleus accumbens dopamine in behavioral activation and effort-related functions. In: Iversen L.L., Iversen S.D., Dunnett S.B., and Bjorklund A. (Eds). Dopamine handbook (2010), Oxford University Press, Oxford 286-300
70. Salamone J.D., Arizzi M.N., Sandoval M.D., Cervone K.M., and Aberman J.E. Dopamine antagonists alter response allocation but do not suppress appetite for food in rats: contrast between the effects of SKF 83566, raclopride, and fenfluramine on a concurrent choice task. Psychopharmacology (Berl) 160 (2002) 371-380
71. Salamone J.D., Betz A.J., Ishiwari K., Felsted J., Madson L., Mirante B., Clark K., Font L., Korbey S., Sager T.N., Hockemeyer J., and Muller C.E. Tremorolytic effects of adenosine A2A antagonists: implications for Parkinsonism. Front Biosci 13 (2008) 3594-3605
72. Salamone J.D., and Correa M. Motivational views of reinforcement: implications for understanding the behavioral functions of nucleus accumbens dopamine. Behav Brain Res 137 (2002) 3-25
73. Salamone J.D., and Correa M. Dopamine/adenosine interactions involved in effort-related aspects of food motivation. Appetite 53 (2009) 422-425
74. Salamone J.D., Correa M., Farrar A., and Mingote S.M. Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits. Psychopharmacology (Berl) 191 (2007) 461-482
75. Salamone J.D., Correa M., Farrar A.M., Nunes E.J., and Pardo M. Dopamine, behavioral economics, and effort. Front Behav Neurosci 3 (2009) 13
76. Salamone J.D., Correa M., Mingote S., and Weber S.M. Nucleus accumbens dopamine and the regulation of effort in food-seeking behavior: implications for studies of natural motivation, psychiatry, and drug abuse. J Pharmacol Exp Ther 305 (2003) 1-8
77. Salamone J.D., Correa M., Mingote S.M., and Weber S.M. Beyond the reward hypothesis: alternative functions of nucleus accumbens dopamine. Curr Opin Pharmacol 5 (2005) 34-41
78. Salamone J.D., Correa M., Mingote S.M., Weber S.M., and Farrar A.M. Nucleus accumbens dopamine and the forebrain circuitry involved in behavioral activation and effort-related decision making: implications for understanding anergia and psychomotor slowing in depression. Curr Psychiatry Rev 2 (2006) 267-280
79. Salamone J.D., Cousins M.S., and Bucher S. Anhedonia or anergia?. Effects of haloperidol and nucleus accumbens dopamine depletion on instrumental response selection in a T-maze cost/benefit procedure. Behav Brain Res 65 (1994) 221-229
80. Salamone J.D., Cousins M.S., and Snyder B.J. Behavioral functions of nucleus accumbens dopamine: empirical and conceptual problems with the anhedonia hypothesis. Neurosci Biobehav Rev 21 (1997) 341-359
81. Salamone J.D., Farrar A.M., Font L., Patel V., Schlar D.E., Nunes E.J., Collins L.E., and Sager T.N. Differential actions of adenosine A1 and A2A antagonists on the effort-related effects of dopamine D2 antagonism. Behav Brain Res 201 (2009) 216-222
82. Salamone J.D., Ishiwari K., Betz A.J., Farrar A.M., Mingote S.M., Font L., Hockemeyer J., Muller C.E., and Correa M. Dopamine/adenosine interactions related to locomotion and tremor in animal models: possible relevance to Parkinsonism. Parkinsonism Relat Disord 14 Suppl 2 (2008) S130-S134
83. Salamone J.D., Kurth P.A., McCullough L.D., Sokolowski J.D., and Cousins M.S. The role of brain dopamine in response initiation: effects of haloperidol and regionally specific dopamine depletions on the local rate of instrumental responding. Brain Res 628 (1993) 218-226
84. Salamone J.D., Steinpreis R.E., McCullough L.D., Smith P., Grebel D., and Mahan K. Haloperidol and nucleus accumbens dopamine depletion suppress lever pressing for food but increase free food consumption in a novel food choice procedure. Psychopharmacology (Berl) 104 (1991) 515-521
85. Salamone J.D., Wisniecki A., Carlson B.B., and Correa M. Nucleus accumbens dopamine depletions make animals highly sensitive to high fixed ratio requirements but do not impair primary food reinforcement. Neuroscience 105 (2001) 863-870
86. Salamone J.D., Zigmond M.J., and Stricker E.M. Characterization of the impaired feeding behavior in rats given haloperidol or dopamine-depleting brain lesions. Neuroscience 39 (1990) 17-24
87. Schiffmann S.N., Jacobs O., and Vanderhaeghen J.J. Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study. J Neurochem 57 (1991) 1062-1067
88. Schweimer J., and Hauber W. Dopamine D1 receptors in the anterior cingulate cortex regulate effort-based decision making. Learn Mem 13 (2006) 777-782
89. Schweimer J., Saft S., and Hauber W. Involvement of catecholamine neurotransmission in the rat anterior cingulate in effort-related decision making. Behav Neurosci 119 (2005) 1687-1692
90. Sink K.S., Vemuri V.K., Olszewska T., Makriyannis A., and Salamone J.D. Cannabinoid CB1 antagonists and dopamine antagonists produce different effects on a task involving response allocation and effort-related choice in food-seeking behavior. Psychopharmacology 196 (2008) 565-574
91. Sokolowski J.D., and Salamone J.D. The role of accumbens dopamine in lever pressing and response allocation: effects of 6-OHDA injected into core and dorsomedial shell. Pharmacol Biochem Behav 59 (1998) 557-566
92. Svenningsson P., Le Moine C., Fisone G., and Fredholm B.B. Distribution, biochemistry and function of striatal adenosine A2A receptors. Prog Neurobiol 59 (1999) 355-396
93. Trevitt J.T., Carlson B.B., Nowend K., and Salamone J.D. Substantia nigra pars reticulata is a highly potent site of action for the behavioral effects of the D1 antagonist SCH 23390 in the rat. Psychopharmacology (Berl) 156 (2001) 32-41
94. van den Bos R., van der Harst J., Jonkman S., Schilders M., and Spruijt B. Rats assess costs and benefits according to an internal standard. Behav Brain Res 171 (2006) 350-354
95. Vezina P., Lorrain D.S., Arnold G.M., Austin J.D., and Suto N. Sensitization of midbrain dopamine neuron reactivity promotes the pursuit of amphetamine. J Neurosci 22 (2002) 4654-4662
96. Wakabayashi K.T., Fields H.L., and Nicola S.M. Dissociation of the role of nucleus accumbens dopamine in responding to reward-predictive cues and waiting for reward. Behav Brain Res 154 (2004) 19-30
97. Walton M.E., Bannerman D.M., and Rushworth M.F. The role of rat medial frontal cortex in effort-based decision making. J Neurosci 22 (2002) 10996-11003
98. Walton M.E., Bannerman D.M., Alterescu K., and Rushworth M.F. Functional specialization within medial frontal cortex of the anterior cingulate for evaluating effort-related decisions. J Neurosci 23 (2003) 6475-6479
99. Walton M.E., Kennerley S.W., Bannerman D.M., Phillips P.E., and Rushworth M.F. Weighing up the benefits of work: behavioral and neural analyses of effort-related decision making. Neural Netw 19 (2006) 1302-1314
100. Wan W., Ennulat D.J., and Cohen B.M. Acute administration of typical and atypical antipsychotic drugs induces distinctive patterns of Fos expression in the rat forebrain. Brain Res 688 (1995) 95-104
101. Wang W.F., Ishiwata K., Nonaka H., Ishii S., Kiyosawa M., Shimada J., Suzuki F., and Senda M. Carbon-11-labeled KF21213: a highly selective ligand for mapping CNS adenosine A(2A) receptors with positron emission tomography. Nucl Med Biol 27 (2000) 541-546
102. Wardas J., Konieczny J., and Lorenc-Koci E. SCH 58261, an A(2A) adenosine receptor antagonist, counteracts Parkinsonian-like muscle rigidity in rats. Synapse 41 (2001) 160-171
103. Worden L.T., Shahriari M., Farrar A.M., Sink K.S., Hockemeyer J., Muller C.E., and Salamone J.D. The adenosine A2A antagonist MSX-3 reverses the effort-related effects of dopamine blockade: differential interaction with D1 and D2 family antagonists. Psychopharmacology (Berl) 203 (2009) 489-499
104. Yin H.H., Ostlund S.B., and Balleine B.W. Reward-guided learning beyond dopamine in the nucleus accumbens: the integrative functions of cortico-basal ganglia networks. Eur J Neurosci 28 (2008) 1437-1448
105. Zhang M., Balmadrid C., and Kelley A.E. Nucleus accumbens opioid, GABAergic, and dopaminergic modulation of palatable food motivation: contrasting effects revealed by a progressive ratio study in the rat. Behav Neurosci 117 (2003) 202-211